ALX Oncology Holdings Inc.

NASDAQ:ALXO

Biotechnology

Healthcare
$0.97 -2.12%

-$0.03 today

Market cap
$134.14M
Beta
0.45
P/E (TTM)
-0.9
EPS (TTM)
-$1.64
52W Low $0.40High $2.66

Volume 0.56M

Average 1.07M

Price history

ALX Oncology Holdings Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-34.01%

Period high

$2.60

Period low

$0.89

Latest

$0.97

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13D/AOct 16, 2026Oct 16, 2026
8-KOct 15, 2026Oct 15, 2026
4Aug 18, 2026Aug 18, 2026
4Aug 18, 2026Aug 18, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
SC 13GJul 27, 2026Jul 27, 2026
4Jul 6, 2026Jul 6, 2026
8-KJun 30, 2026Jun 30, 2026
8-KJun 26, 2026Jun 26, 2026
8-KJun 11, 2026Jun 11, 2026
SC 13D/AMay 27, 2026May 27, 2026
SC 13G/AMay 15, 2026May 15, 2026
SC 13G/AMay 15, 2026May 15, 2026

Competitors

Who does ALX Oncology Holdings Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ALXO's filings, answered from its disclosures.

What is the latest ALXO filing?

The latest filing shown is SC 13D/A dated Oct 16, 2026.

How many recent filings does ALXO have?

Intrinsic Alpha currently shows 20 recent filings for ALXO.